Cell Therapy & Vaccines
JPT Peptide Technologies has developed a variety of unique peptide-based technologies allowing systematic B- and T-cell epitope discovery, immune monitoring and clinical development of immunotherapy and vaccines.
In contrast to other approaches on the market, our technologies allow monitoring of individual epitope patterns as well as epitope spreading and address natural sequence diversity and post-translational modifications.
Our peptides and services have been used successfully in numerous projects leading to novel approaches in cancer, infection, autoimmune disease and allergy therapy.